| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 12 |
| 1 | PACLITAXEL | 12 |
| 2 | GABAPENTIN | 9 |
| 3 | MORPHINE SULFATE | 9 |
| 4 | PREDNISONE | 7 |
| 5 | TACROLIMUS | 7 |
| 6 | MYCOPHENOLATE MOFETIL | 6 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 6 |
| 8 | TACROLIMUS OINTMENT 0.1% | 6 |
| 9 | FUROSEMIDE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NISOLDIPINE | 1 | 0.0008 |
| 1 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 2 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 3 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 1 | 0.0003 |
| 4 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 5 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | 1 | 0.0002 |
| 6 | DACARBAZINE | 1 | 0.0001 |
| 7 | PACLITAXEL | 12 | 0.0001 |
| 8 | CANDESARTAN CILEXETIL | 3 | 0.0001 |
| 9 | LUBIPROSTONE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 2 | Microtubule Inhibitor [EPC] | 13 | 0.0001 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 12 | 0.0000 |
| 5 | Nitroimidazole Antimicrobial [EPC] | 2 | 0.0000 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 2 | 0.0000 |
| 7 | Xanthine Oxidase Inhibitor [EPC] | 4 | 0.0000 |
| 8 | Aromatase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Methylxanthine [EPC] | 1 | 0.0000 |